Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium

... issues, today released its updated Pharmacor rheumatoid Arthritis report which now includes patient ... Humira in the treatment cascade for rheumatoid arthritis. Phase II data shows that fostamatinib ... of the other novel oral agent in development for rheumatoid arthritis--Pfizer's Jak-3 inhibitor CP-690550," ...

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

... arthritis (JIA), formerly called juvenile rheumatoid arthritis, in 1999, and this is the only ... approved in 1998 for adult moderate to severe rheumatoid arthritis and has more than 17 years of ... function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate ...

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

... 2 clinical trial of LX2931 in patients with rheumatoid arthritis . LX2931 is an orally-delivered, ... of LX2931 with methotrexate in patients with rheumatoid arthritis, with no clinically significant ... biologic therapies in treating patients with rheumatoid arthritis," said Philip M. Brown , M.D., J.D., ...

For Treatment of Rheumatoid Arthritis, Surveyed Rheumatologists and Patients Differ In Their Perception of Bristol-Myers Squibb's Orencia

... of Bristol-Myers Squibb's Orencia is low among rheumatoid arthritis agents. Rheumatologists are less ... of reimbursement restrictions compared to other rheumatoid arthritis brands. In contrast, surveyed ... The new report entitled Brand Perceptions in rheumatoid Arthritis also finds that Orencia's ...

Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013

... and healthcare issues, finds that the rheumatoid arthritis drug market in Brazil will grow from ... The new Emerging Markets report entitled rheumatoid Arthritis in Brazil also finds that survey ... for agents within key drug classes for rheumatoid arthritis. While Enbrel emerges as the patient ...

Autism May Be Linked to Mom's Autoimmune Disease

... autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and celiac disease have up to a three ... and a maternal history of type 1 diabetes and rheumatoid arthritis had been found in earlier research, the ... 1 diabetes is a little less than two times, for rheumatoid arthritis it's about 1.5 times and for celiac ...

New Drug Promising Against Rheumatoid Arthritis

... drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other ... of Rheumatology criteria for assessment of rheumatoid arthritis (ACR 20), compared with 18 percent of ... reduces the signs and symptoms of active rheumatoid arthritis and improves physical function in ...

Better access to info and dialogue with HCPs on sexual issues for rheumatology patients

... In the first qualitative study of 23 rheumatoid arthritis (RA) patients, the respondents reported ... duration 2-34 years) (including those with rheumatoid arthritis, juvenile rheumatoid arthritis, spondylarthropathy; 13 men, 10 women) ...

ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress

... highlight benefits of ACTEMRA as a treatment for rheumatoid arthritis - NUTLEY, N.J., June 4 ... "Efficacy of Tocilizumab (TCZ) in rheumatoid Arthritis (RA): Interim Analysis of Long-term ... Methotrexate (MTX) Monotherapy in Patients with rheumatoid Arthritis (RA) with No Prior MTX or DMARD ...

Treating gum disease helps rheumatoid arthritis sufferers

... from gum disease and also have a severe form of rheumatoid arthritis, reduced their arthritic pain, number ... gums, then patients with a severe kind of active rheumatoid arthritis reported improvement on the signs and ... This is not the first time that gum disease and rheumatoid arthritis have been linked. According to another ...

Arthritis drug might prove effective in fighting the flu, study suggests

... have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in ... which is commonly used to treat people with rheumatoid arthritis. The mice had been given "memory" ... Food and Drug Administration for treatment of rheumatoid arthritis. The drug is not approved for treating ...

For the Treatment of Rheumatoid Arthritis, Market Share for TNF-alpha Inhibitors Will Decrease Through 2018

... healthcare issues finds that, in the treatment of rheumatoid arthritis, the market share for TNF-alpha ... Abbott/Eisai's Humira accounted for 80 percent of rheumatoid arthritis drug sales in the United States, ... Japan. The new Pharmacor report entitled rheumatoid Arthritis finds that alternative biologics such ...

UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis

... suffering from moderately to severely active rheumatoid arthritis - Patients treated with Cimzia(R), ... adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia(R) can be dosed at 400 mg ... "The approval of Cimzia(R) for moderate to severe rheumatoid arthritis in the U.S. is a major milestone for ...

SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis and active ... an effective once-monthly treatment option. rheumatoid arthritis, psoriatic arthritis and ankylosing ... been studied in a broad range of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing ...

Schering-Plough Reports Financial Results for 2009 First Quarter

... in Japan and certain other Asian markets) for rheumatoid arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic ... the first once-monthly, subcutaneous therapy for rheumatoid arthritis, psoriatic arthritis and ankylosing ...

AAI honors Chen Dong for breakthrough T lymphocyte research

... such as asthma, and autoimmune illnesses, such as rheumatoid arthritis and multiple sclerosis. His ... have advanced drugs to clinical trials for rheumatoid arthritis and psoriasis based on Dong's work. ... receptors from their T cells to a mouse model of rheumatoid arthritis. There was plenty of interferon gamma ...

Once-a-Year Drug Helps Counter Steroid-Linked Bone Loss

... pill at restoring bone for patients with asthma, rheumatoid arthritis, study found FRIDAY, April 10 (HealthDay News) -- Patients with rheumatoid arthritis or asthma often need to take a ... diseases, including asthma, lupus and rheumatoid arthritis. And it did so more effectively than a ...

Rheumatoid Arthritis Therapeutics in Taiwan

... TAIPEI, Taiwan, April 10 /PRNewswire/ -- rheumatoid arthritis (RA) is a systemic disease or an ... (AS) and system lupus erythmatosus (SLE), rheumatoid arthritis (RA) is one of the most common ... excluded by any one test. The most common test is rheumatoid factor (RF). The other supporting tests are: ...

Rheumatoid Arthritis Therapeutics in China

... JAKARTA, Indonesia, April 9 /PRNewswire/ -- rheumatoid arthritis (RA) is a systemic disease or an ... ) In 2007, the prevalence of rheumatoid arthritis (RA) in China was 0.3 percent, and has ... excluded by any one test. The most common test is rheumatoid factor (RF). The other supporting tests are: ...

Rheumatoid Arthritis Therapeutics in Philippines

... MANILA, Philippines, April 6 /PRNewswire/ -- rheumatoid arthritis (RA) is a systemic disease or an ... ) rheumatoid arthritis (RA) is one of the leading causes of ... excluded by any one test. The most common test is rheumatoid factor (RF). The other supporting tests are: ...

Rheumatoid Arthritis Therapeutics in Thailand

... BANGKOK, April 6 /PRNewswire/ -- rheumatoid arthritis (RA) is a systemic disease or an ... of symptoms, patient history, blood tests, rheumatoid factor (RF), anti-cyclic citrullinated peptide ... ) rheumatoid arthritis (RA) is a relatively less common ...

Living Near Major Road May Boost Rheumatoid Arthritis Risk

... of traffic pollution have an increased risk of rheumatoid arthritis, a new study suggests. Researchers ... roads were 31 percent more likely to develop rheumatoid arthritis (RA) than those who lived more than 200 ... factors account for less than 50 percent of rheumatoid arthritis risk, and that environmental factors ...

Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia

... KUALA LUMPUR, Malaysia, March 31 /PRNewswire/ -- rheumatoid arthritis (RA) is a systemic disease or an ... excluded by any one test. The most common test is rheumatoid factor (RF). The other supporting tests are: ... RA. It is also the most used form of treatment in rheumatoid arthritis, especially with generic forms ...

Immune cells from patients with rheumatoid arthritis have prematurely aged chromosomes

... cells, from patients with the autoimmune disease rheumatoid arthritis are worn out and prematurely aged, ... from healthy people, T cells from patients with rheumatoid arthritis have trouble turning on the enzyme that ... of the National Academy of Sciences . In rheumatoid arthritis, T cells are chronically ...

Rigel Announces Fourth Quarter and Year End 2008 Financial Results

... with the Phase 2b clinical trials of R788 in rheumatoid arthritis (TASKi2 and TASKi3). Stock-based ... 2b trials, TASKi2 and TASKi3, for patients with rheumatoid arthritis in July and August of 2009, ... in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well ...

Rheumatoid Arthritis Drugs Raise Shingles Risk

... -- A class of medications used widely to treat rheumatoid arthritis and other autoimmune diseases might ... reach clinical significance, and, Fiocco added, rheumatoid arthritis itself probably increases the risk of ... over, but it has not been studied in those with rheumatoid arthritis or people taking TNF blockers, the ...

Current and Emerging Therapies Have No Advantage Over Enbrel in Reducing the Signs and Symptoms of Rheumatoid Arthritis

... Will Earn Decision Resources' Gold Standard for rheumatoid Arthritis in 2012, According to a New Report from ... effect on reducing the signs and symptoms of rheumatoid arthritis at one year is the attribute that most ... agent. The new report entitled rheumatoid Arthritis: A Novel Oral Therapy Must Satisfy ...

Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012

... will propel Roche to sixth position in the rheumatoid arthritis market by 2012. Driving factors include ... new report entitled Brands & Strategies : rheumatoid Arthritis , physicians indicate that Actemra's ... to secure significant market share in the mature rheumatoid arthritis market. Promotional spending doubled ...

CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine

... the initiation of a definitive study of its new rheumatoid arthritis treatment vaccine (CEL-2000) to ... Enbrel(R), a leading treatment for people with rheumatoid arthritis. "We are very excited to see a ... of other potential advantages over existing rheumatoid arthritis treatments, such as Enbrel. The data ...

GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –

... diseases such as lupus, psoriasis, and rheumatoid arthritis. "Our alliance with GSK ... like systemic lupus erythematosus, psoriasis and rheumatoid arthritis," commented Jose Carlos ... such as lupus, inflammatory skin disorders, and rheumatoid arthritis. About Dynavax Dynavax ...

Genome-wide Association Studies Must Account for Ancestry

... For instance, Dr. Gregersen studies rheumatoid arthritis, and in 2004 his team discovered an ... this variant. This variant increases the risk for rheumatoid arthritis and a number of other autoimmune ... found that it is not a risk factor for rheumatoid arthritis in the Asian population. That means ...

MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks

... a wide array of research on and data for rheumatoid arthritis, Crohn's disease, ulcerative colitis ... uses in the treatment of Crohn's disease, rheumatoid arthritis, ulcerative colitis and ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, ...

EntreMed Reports Clinical Program Progress and Company Update

... for its ENMD-2076 kinase inhibitor and rheumatoid arthritis programs and focuses down on its key ... inhibitor, ENMD-2076, and for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to select an ... than are anticipated for the treatment of rheumatoid arthritis. Based on the FDA's review, the ...

UCB Announces 2008 UCB Family RA Scholarship Program Recipients

... 10 Individuals Reaching Beyond the Boundaries of rheumatoid Arthritis and Fulfilling Educational Ambitions ... of someone with the disease. The symptoms of rheumatoid arthritis can make even the simplest everyday ... to overcoming the challenges posed by rheumatoid arthritis," said Michael Weinblatt, M.D., ...

New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers

... -- UCB announced today findings from large-scale rheumatoid arthritis (RA) surveys collectively called the ... agree, %) 37 52 About rheumatoid Arthritis rheumatoid arthritis (RA) is a progressive autoimmune ...

Etanercept, Methotrexate Safe for Juvenile RA

... for long-term, continuous treatment of juvenile rheumatoid arthritis, new research finds. In a ... continuous therapy for the treatment of juvenile rheumatoid arthritis," he said. The study was expected to ... The Nemours Foundation has more about juvenile rheumatoid arthritis . -- Robert ...

Rheumatoid Arthritis a Threat to the Heart

... (HealthDay News) -- People newly diagnosed with rheumatoid arthritis face twice the risk of a heart attack, ... study, Kremers' team followed 38 patients with rheumatoid arthritis who had suffered a heart attack. Then they compared these patients with patients without rheumatoid arthritis who also had a heart attack. The ...

UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign

... program: "Within Our Reach: Finding a Cure for rheumatoid Arthritis." The announcement was made at the ... to the patients and physicians who deal with rheumatoid arthritis (RA) every day." Within Our Reach is ... this donation will help us achieve that goal." rheumatoid arthritis (RA) is a progressive autoimmune ...

Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis

... measures of efficacy in moderate to severe rheumatoid arthritis (RA) patients completing up to 10 years ... (baseline: N=644, 10-year: N=255). ABOUT rheumatoid ARTHRITIS According to the Arthritis ... was first approved in 1998 for moderate to severe rheumatoid arthritis and was later approved to treat ...

Rigel to Webcast Investor Update on October 27, 2008

... in two Phase 2b clinical trials in patients with rheumatoid arthritis, as well as Phase 2 clinical trials in ... Arthritis Title: 1189 - Treatment of rheumatoid Arthritis (RA) with a Syk Kinase Inhibitor: A ... in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well ...